GPC2 Is a Potential Diagnostic, Immunological, and Prognostic Biomarker in Pan-Cancer
Guo-Ming Chen(Institute of High Energy Physics), Yibin Feng(Zhejiang Lab), Xiaoxiao Lin(Guangzhou University of Chinese Medicine), Zhuoyao Li(National Natural Science Foundation of China), Jiyuan Zheng(Guangzhou University of Chinese Medicine), Danyun Li(Gansu Provincial Hospital), Yuanjun Lu(East China University of Science and Technology), Qiqi Chen(Guangzhou University of Chinese Medicine), Hui Liao(Guangzhou University of Chinese Medicine), Nan Zhong(Guangzhou University of Chinese Medicine), Ning Wang(Shanghai Ninth People's Hospital), Cheng Zhang(Georgia Institute of Technology), Dongqiang Luo(Guangzhou University of Chinese Medicine), Yau-Tuen Chan(University of Hong Kong), Qing Ren(Chinese University of Hong Kong)
Cited by 75
Related Papers
The Reactive Oxygen Species in Macrophage Polarization: Reflecting Its Dual Role in Progression and Treatment of Human Diseases
|Oxidative Medicine and Cellular Longevity|2016|624
Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy
|Molecular Cancer|2020|491
Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses
|Frontiers in Microbiology|2020|442
Health Functions and Related Molecular Mechanisms of Tea Components: An Update Review
|International Journal of Molecular Sciences|2019|407
Epigenetic regulation of ferroptosis via ETS1/miR-23a-3p/ACSL4 axis mediates sorafenib resistance in human hepatocellular carcinoma
|Journal of Experimental & Clinical Cancer Research|2022|209